Moore Capital Management, LP Pulmonx Corp Transaction History

Moore Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$15.35 - $23.99 $423,306 - $661,572	-27,577 Reduced 52.3%	25,152 $419,000
Q2 2022 Aug 15, 2022	SELL	$14.0 - $27.95 $1.37 Million - $2.73 Million	-97,506 Reduced 64.9%	52,729 $776,000
Q1 2022 May 16, 2022	SELL	$21.13 - $35.65 $1.51 Million - $2.55 Million	-71,515 Reduced 32.25%	150,235 $3.73 Million
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $1.67 Million - $2.54 Million	-56,212 Reduced 20.22%	221,750 $7.11 Million
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $6.1 Million - $7.54 Million	169,557 Added 156.41%	277,962 $10 Million

Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $2.27 Million - $2.9 Million	60,395 Added 125.8%	108,405 $4.78 Million
Q1 2021 May 17, 2021	SELL	$44.0 - $67.54 $1.82 Million - $2.79 Million	-41,275 Reduced 46.23%	48,010 $2.2 Million
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $3.51 Million - $6.16 Million	89,285 New	89,285 $6.16 Million

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.